Aptevo Therapeutics Inc. SC 13G and SC 13G/A reports

Location
2401 4 Th Ave., Suite 1050, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/19/2024, 01:27 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Feb 14, 2024
SC 13G/A Report APTEVO THERAPEUTICS INC. Feb 14, 2023
SC 13G/A Report Feb 10, 2022
SC 13G/A Report SCHEDULE 13G (AMENDMENT #1) Feb 16, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report Feb 12, 2021
SC 13G/A Report Feb 12, 2021
SC 13G/A Report Feb 11, 2021
SC 13G/A Report AMENDMENT TO FORM SC 13G Nov 27, 2020
SC 13G Report Nov 16, 2020
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Mar 11, 2020
SC 13G/A Report SCHEDULE 13G (AMENDMENT NO. 1) Feb 14, 2020
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 14, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report Feb 13, 2020
SC 13G/A Report Feb 13, 2020
SC 13G/A Report SCHEDULE 13G/A Feb 12, 2020
SC 13G Report Mar 20, 2019
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Mar 20, 2019
SC 13G Report Mar 18, 2019
SC 13G Report SCHEDULE 13G Mar 12, 2019
SC 13G/A Report SC 13G/A Feb 12, 2019
SC 13G Report Feb 12, 2019
SC 13G/A Report SCHEDULE 13G/A Feb 8, 2019
SC 13G/A Report SC 13G/A Feb 14, 2018
SC 13G Report SCHEDULE 13G Feb 9, 2018
SC 13G/A Report Jul 10, 2017
SC 13G/A Report SC 13G/A Feb 14, 2017
SC 13G Report Jan 30, 2017
SC 13G Report SC 13G Nov 18, 2016
SC 13G Report SC 13G Aug 3, 2016